HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice.

Abstract
The contribution of nociceptin/orphanin FQ (N/OFQ) to reserpine-induced Parkinsonism was evaluated in mice. A battery of motor tests revealed that reserpine caused dose-dependent and long-lasting motor impairment. Endogenous N/OFQ sustained this response because N/OFQ peptide (NOP) receptor knockout (NOP(-/-) ) mice were less susceptible to the hypokinetic action of reserpine than wild-type (NOP(+/+) ) animals. Microdialysis revealed that reserpine elevated glutamate and reduced GABA levels in substantia nigra reticulata, and that resistance to reserpine in NOP(-/-) mice was accompanied by a milder increase in glutamate and lack of inhibition of GABA levels. To substantiate this genetic evidence, the NOP receptor antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H benzimidazol-2-one (J-113397) simultaneously reduced akinesia and nigral glutamate levels in reserpinized NOP(+/+) mice, being ineffective in NOP(-/-) mice. Moreover, repeated J-113397 administration in reserpinized mice resulted in faster recovery of baseline motor performance which was, however, accompanied by a loss of acute antiakinetic response. The short-term beneficial effect of J-113397 was paralleled by normalization of nigral glutamate levels, whereas loss of acute response was paralleled by loss of the ability of J-113397 to inhibit glutamate levels. We conclude that endogenous N/OFQ contributes to reserpine-induced Parkinsonism, and that sustained NOP receptor blockade produces short-term motor improvement accompanied by normalization of nigral glutamate release.
AuthorsMattia Volta, Omar S Mabrouk, Simone Bido, Matteo Marti, Michele Morari
JournalJournal of neurochemistry (J Neurochem) Vol. 115 Issue 6 Pg. 1543-55 (Dec 2010) ISSN: 1471-4159 [Electronic] England
PMID20950413 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.
Chemical References
  • Benzimidazoles
  • Excitatory Amino Acids
  • J 113397
  • Opioid Peptides
  • Piperidines
  • nociceptin
  • Reserpine
Topics
  • Animals
  • Benzimidazoles (pharmacology)
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acids (agonists, physiology)
  • Mice
  • Mice, Knockout
  • Motor Activity (drug effects, physiology)
  • Opioid Peptides (antagonists & inhibitors, deficiency, physiology)
  • Parkinsonian Disorders (chemically induced, physiopathology)
  • Piperidines (pharmacology)
  • Reserpine (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: